查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1676944

經頸靜脈經子宮頸門靜脈分流術市場按產品類型、程序類型、材料類型、應用和最終用戶分類 - 2025 年至 2030 年全球預測

Transjugular Intrahepatic Portosystemic Shunt Market by Product Type, Procedure Type, Material Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年經子宮頸肝內門體分流術市場價值為 1.0255 億美元，預計 2025 年將成長至 1.0678 億美元，複合年成長率為 4.27%，預計到 2030 年將達到 1.3181 億美元。

主要市場統計數據
基準年 2024 年 1.0255億美元
預計 2025 年 1.0678億美元
預測年份 2030 1.3181億美元
複合年成長率（%） 4.27％

經子宮頸肝內門靜脈分流術（TIPS）是治療門靜脈高壓及其相關併發症的重要治療方法。這份全面的執行摘要深入探討了 TIPS 市場的複雜動態，詳細介紹了推動成長和改變患者治療結果的技術創新、不斷發展的程序和策略市場細分。

在醫療水準快速進步的今天，TIPS作為緩解肝硬化、門脈高壓、布加症候群等併發症的極其重要的治療方法而備受關注。除了臨床成功之外，對病人安全和術後護理的日益重視也引起了從醫院到專科診所等廣泛終端使用者的興趣。隨著監管環境的不斷發展和新型醫療設備治療效果的提高，相關人員正在努力應對嚴峻的市場挑戰，這些挑戰不僅與臨床試驗和產品創新有關，還與競爭動態和成本限制有關。

本摘要詳細介紹了 TIPS 市場內的變革性變化、揭示關鍵產業趨勢的嚴格細分方法，以及為尋求持續市場成功的產業領導者提供的策略建議。在定性和定量洞察的支持下，分析已成為快速發展的醫療保健模式中策略決策的基礎。

經子宮頸靜脈肝內門體分流術市場的轉型

在過去的十年中，TIPS格局發生了變革，重新定義了市場結構和價值提案。有幾個關鍵因素推動了這一演變。

一個關鍵的改變是技術創新步伐加快。專為 TIPS 設計的醫療設備現在擁有先進的功能，可提高分流器放置的準確性並改善患者的治療效果。這項進展得到了新研究的補充，檢驗了臨床效果，增強了醫生和患者的信心。從球囊擴張器到導管到導絲，輔助設備的發展使得手術程序變得現代化，從而使得手術更加順利，並降低了手術風險。

同時，為了跟上這些技術創新，各大廠商和科研機構都在積極投入研發。監管機構也在調整指導方針，以支持引入創新治療方法，同時確保安全性和合規性。這些進步的政策，加上許多地區的市場自由化，為相關人員探索新的臨床應用和工藝改進提供了充足的機會。

另一個變革力量是臨床資料與商業主導洞察的融合。治療機構擴大使用真實世界證據來改進產品開發和改善患者通訊協定，推動從傳統治療方法轉向更全面的、技術支援的方法的轉變。這種資料主導的洞察力和創新產品的結合正在改變競爭格局，並促進設備製造商、醫療保健提供者和研究機構之間的合作和策略聯盟。

本質上，市場不僅正在經歷從傳統程序技術向最尖端科技整合的顯著轉變，而且還正在經歷向更加以患者為中心的轉變。有效利用這些動態的行業參與者將能夠推動未來市場成長，同時改善不同患者群體的臨床結果。

TIPS 市場的關鍵細分洞察

TIPS 市場的細分分析提供了多層次的觀點，可協助產業相關人員識別成長機會並了解市場多樣化。根據產品類型，市場主要分為配件和支架。在附屬設備領域，球囊擴張器、導管和導絲等組件受到嚴格審查，它們每個都在提高手術準確性和患者安全性方面發揮著至關重要的作用。相較之下，支架類別分為裸金屬支架、藥物釋放型支架和分段支架，突顯了針對特定臨床場景的材料和設計的演變。

根據手術類型，我們檢查選擇性分流術和緊急分流術。緊急分流器通常需要快速部署且不影響功效，重點在於簡化協定並確保設備在時間敏感的情況下的可靠性。另一方面，在選擇性分流術中，規劃和計算方法已經得到更廣泛的發展，可以根據個別患者的需求制定干涉措施。

金屬支架以其耐用性和長期性能而聞名，而聚合物支架則具有靈活性和成本效益，兩者之間存在明顯的差異。每種材料類型都有不同的臨床益處和風險狀況，這將影響市場採用和定價策略。

此外，對應用領域的分析表明，該市場旨在滿足各種與肝臟相關的健康狀況。布德-加氏症候群、C型肝炎、肝硬化和門脈高壓等疾病反映了 TIPS 手術治療的多功能性，但也凸顯了治療這些複雜疾病的挑戰。最後，基於最終用戶細分的評估顯示範圍廣泛，包括門診手術中心、醫院、研究機構和專科診所。這種分佈凸顯了TIPS程式在各種醫療保健基礎設施中的廣泛接受度和實用性，進一步增強了市場需求並刺激了整個設備類別的創新。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 肝硬化、門脈高壓等肝病發生率增加
      • 由於恢復時間縮短，微創手術的採用率增加
    • 限制因素
      • 肝內門體分流術的安全性問題和潛在併發症
    • 機會
      • 使用人工智慧制定個人化的 TIPS 治療計劃以改善患者治療效果
      • 利用材料技術進步提高 TIPS 設備的有效性和安全性
    • 任務
      • 與 TIPS 程序相關的保險覆蓋不足和報銷問題
  • 市場區隔分析
    • 產品類型：微創手術輔助設備需求不斷成長
    • 應用：門脈高壓治療中對TIPS手術的需求日益增加
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章經子宮頸肝內門靜脈分流術市場（依產品類型）

  • 附屬設備
    • 球囊擴張器
    • 導管
    • 導管導引線
  • 支架
    • 裸金屬支架
    • 藥物釋放型支架
    • 分段支架

第7章經子宮頸肝內門靜脈分流術市場（依手術類型）

  • 選擇性分流
  • 緊急分流

第 8 章經子宮頸肝內門靜脈分流術市場（依材料類型）

  • 金屬支架
  • 聚合物

經子宮頸肝內門靜脈分流術市場（依應用）

  • 布加氏症候群
  • C型肝炎
  • 肝硬化
  • 門脈高壓症

第 10 章經子宮頸肝內門靜脈分流術市場（依最終使用者）

  • 門診手術中心
  • 醫院
  • 研究組織
  • 專科門診

11. 美洲經子宮頸肝內門靜脈分流術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太地區經子宮頸肝內門靜脈分流術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲經頸經子宮頸肝內門靜脈分流術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • AngioDynamics Inc.
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Medtronic
  • Merit Medical Systems, Inc.
  • Siemens Healthcare Limited
  • Sirtex Medical Inc.
  • Terumo Medical Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-562E923A956A

The Transjugular Intrahepatic Portosystemic Shunt Market was valued at USD 102.55 million in 2024 and is projected to grow to USD 106.78 million in 2025, with a CAGR of 4.27%, reaching USD 131.81 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 102.55 million
Estimated Year [2025] USD 106.78 million
Forecast Year [2030] USD 131.81 million
CAGR (%) 4.27%

The transjugular intrahepatic portosystemic shunt (TIPS) represents a critical intervention in the management of portal hypertension and its ensuing complications. This comprehensive executive summary delves into the complex dynamics of the TIPS market, detailing the technological innovations, evolving procedural techniques, and strategic market segmentation that drive growth and transform patient care outcomes.

In today's era of rapid medical advancement, TIPS procedures have emerged as a pivotal treatment option particularly aimed at alleviating complications associated with liver cirrhosis, portal hypertension, and conditions like Budd-Chiari Syndrome. Clinical successes combined with heightened emphasis on patient safety and post-procedure care have bolstered interest across a range of end-users from hospitals to specialty clinics. As regulatory landscapes continue to evolve and novel medical devices enhance the intervention's efficacy, stakeholders find themselves navigating not only clinical trials and product innovation but formidable market challenges tied to competitive dynamics and cost-constraints.

This summary provides an in-depth look at the transformative shifts within the TIPS market, rigorous segmentation approaches that illuminate key industry trends, and strategic recommendations designed for industry leaders targeting sustained market success. The analysis supported by qualitative and quantitative insights sets a foundation that underpins strategic decision-making in a rapidly evolving healthcare paradigm.

Transformative Shifts in the TIPS Market Landscape

Over the past decade, the TIPS landscape has undergone transformative shifts that have redefined the market's structure and value proposition. Several key factors are driving this evolution.

One significant shift is the accelerated pace of technological innovation. Medical devices specifically designed for TIPS now boast advanced features, greater precision in shunt placement, and improved patient outcomes. This evolution is complemented by new research studies that validate clinical efficacy, driving confidence among both practitioners and patients. The development of accessory devices-ranging from balloon expanders to catheters and guiding wires-has modernized procedural techniques, enabling smoother operations and reduced operative risks.

Concurrently, these innovations have been met with rigorous reinvestments in research and development driven by leading manufacturers and research institutes alike. Regulatory bodies are also adapting their guidelines to support the introduction of innovative therapies while ensuring safety and compliance. These forward-thinking policies, coupled with market liberalization in many regions, have provided ample opportunity for stakeholders to explore new clinical applications and process improvements.

Another transformative force is the merging of clinical data with commercially driven insights. Institutions are increasingly leveraging real-world evidence to refine product development and improve patient protocols, catalyzing a shift from traditional treatment modalities to more integrated, technology-enhanced approaches. This blend of data-driven insights and innovative product offerings has reshaped the competitive landscape, inviting collaboration and strategic alliances among device manufacturers, healthcare providers, and research agencies.

In essence, the market is experiencing a notable shift not only from conventional procedural methods to cutting-edge technological integration but also towards a more patient-centric approach. Industry players who effectively harness these dynamics are well positioned to drive future market growth while enhancing clinical outcomes for a diverse patient demographic.

Key Segmentation Insights in the TIPS Market

The segmentation analysis of the TIPS market provides a multi-layered view that assists industry stakeholders in identifying growth opportunities and understanding market diversification. In reviewing product type, the market is predominantly divided between accessory devices and stents. The segment for accessory devices is meticulously examined to include components such as balloon expanders, catheters, and guiding wires, each of which plays a vital role in improving procedural accuracy and patient safety. In contrast, the stent category is further nuanced into bare metal stents, drug-eluting stents, and sectional stents, highlighting the evolution of materials and design tailored to specific clinical scenarios.

A separate segmentation perspective is offered by procedure type, where both elective and emergency shunts are scrutinized. Recognizing that emergency shunts often require rapid deployment without compromising efficacy, there has been an emphasis on streamlining protocols and ensuring device reliability under time-sensitive conditions. This is balanced with elective shunts where the planning and computational methodologies are more extensively developed to tailor interventions to individual patient needs.

Material type segmentation also provides intriguing insights into the market's progression, with a clear division between metallic stents, known for their durability and long-term performance, and polymer-based solutions that offer flexibility and cost-effectiveness. Each material type demonstrates differing clinical benefits and risk profiles, which in turn influence market adoption and pricing strategies.

Moreover, analysing the application segment reveals that the market is designed to address a wide spectrum of liver-related health conditions. Conditions such as Budd-Chiari Syndrome, Hepatitis C, liver cirrhosis, and portal hypertension not only reflect the therapeutic versatility of TIPS procedures but also underscore the challenges in managing these complex diseases. Finally, evaluation based on end-user segments indicates a diverse range that includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. The distribution underscores the widespread acceptance and utility of TIPS procedures across various healthcare infrastructures, further bolstering market demand and encouraging innovation across device classes.

Based on Product Type, market is studied across Accessory Devices and Stents. The Accessory Devices is further studied across Balloon Expanders, Catheters, and Guiding Wires. The Stents is further studied across Bare Metal Stents, Drug-Eluting Stents, and Sectional Stents.

Based on Procedure Type, market is studied across Elective Shunts and Emergency Shunts.

Based on Material Type, market is studied across Metallic Stents and Polymers.

Based on Application, market is studied across Budd-Chiari Syndrome, Hepatitis C, Liver Cirrhosis, and Portal Hypertension.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Research Institutes, and Specialty Clinics.

Regional Insights and Market Penetration Trends

An examination of regional trends reveals a multifaceted market with distinct growth patterns across geographies. The Americas have exhibited robust market growth driven by high healthcare spending, advanced clinical infrastructure, and strong research investments. There is significant adoption of TIPS procedures in this region, supported by a well-coordinated network of tertiary care centers and a proactive regulatory environment that facilitates innovation.

In the Europe, Middle East & Africa region, market dynamics are influenced by a combination of mature healthcare frameworks in developed European countries and evolving infrastructure in various MEA nations. Here, incremental investments in healthcare technology have enhanced the operational efficiency of TIPS procedures, while cross-border collaborations and knowledge-sharing initiatives are fostering greater clinical confidence.

The Asia-Pacific region is emerging as a critical growth driver for the TIPS market. Rapid urbanization, improving healthcare facilities, and increased access to cutting-edge medical interventions are fueling demand in this region. Local and international manufacturers are keenly tuning into the region's vast potential by customizing their product offerings to suit the demographic and clinical idiosyncrasies particular to diverse markets in Asia-Pacific. Collectively, these regional variations offer valuable insights that can assist market participants in tailoring their approaches to meet localized needs and drive sustained market penetration.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Strategic Insights into Leading Industry Players

A competitive analysis of the TIPS market underscores the presence of major players with significant influence over technological and clinical advancements in the field. Companies such as AngioDynamics Inc. and Argon Medical Devices, Inc. are at the forefront of driving product innovations, particularly in designing state-of-the-art accessory devices and advanced stent solutions. Their focus on developing balloon expanders, catheters, and guiding wires continues to set industry benchmarks for procedural efficiency and safety.

Becton, Dickinson and Company and Boston Scientific Corporation have harnessed their extensive research capabilities to introduce breakthrough technologies that enhance device performance while optimizing cost efficiency. The rigorous R&D efforts spearheaded by leaders like Cook Group Incorporated and Medtronic have been pivotal in ensuring that clinical outcomes are both safe and reproducible.

Merit Medical Systems, Inc. along with Siemens Healthcare Limited, have contributed to streamlining manufacturing processes, further refining the precision of TIPS-related devices. Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc. have also carved niche yet decisive market segments by focusing on specific device innovations tailored to meet varied clinical requirements.

The strategic interplay among these top companies is fostering a competitive yet collaborative environment in the market. Their continuous improvements in device design, coupled with advancements in procedural technology, create immense value for healthcare providers. This, in turn, ensures that patient outcomes remain at the core of innovation, thereby delivering a blend of operational excellence and clinical safety that sustains industry growth over time.

The report delves into recent significant developments in the Transjugular Intrahepatic Portosystemic Shunt Market, highlighting leading vendors and their innovative profiles. These include AngioDynamics Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Medtronic, Merit Medical Systems, Inc., Siemens Healthcare Limited, Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Growing Market Leaders

Industry leaders looking to secure a competitive edge in the TIPS market should embrace a multi-pronged strategy that promotes innovation, operational efficiency, and market adaptability. A primary recommendation is to advance research and development initiatives not only in terms of hardware-such as improving the design of accessory devices and stents-but also in integrating digital health technologies that allow for real-time data monitoring and outcomes analysis. Collaboration between surgeons, researchers, and technologists can pave the way for developing devices that are adaptable to both elective and emergency procedural demands.

Another essential strategy involves expanding the geographical footprint by tailoring device solutions to the unique needs of various regions. Understanding local regulatory frameworks and healthcare practices is key; thus, an investment in regional market research can unveil opportunities to customize products and streamline distribution channels. Leaders are encouraged to foster strong alliances with local hospitals, research institutes, and specialty clinics to build a resilient network that is capable of addressing both acute and chronic conditions linked to portal hypertension, liver cirrhosis, and other liver-associated diseases.

On the operational front, implementing best practices in manufacturing and quality assurance can significantly reduce production costs while enhancing reliability. By leveraging automation and adopting standardized protocols across multiple facilities, companies can achieve economies of scale and ensure consistent device quality irrespective of the production location.

Lastly, a robust post-market surveillance system is crucial in maintaining safety and efficacy benchmarks. Industry players should invest in systems that facilitate rapid feedback from healthcare providers, enabling quick adjustments to device design and procedural protocols. This proactive approach not only improves patient outcomes but enhances market reputation, supporting long-term brand loyalty and trust among medical professionals.

Collectively, these actionable strategies serve as a roadmap for leaders intent on not just maintaining relevance but also in spearheading innovation and operational excellence in the TIPS market.

Conclusion: Steering the Future of TIPS Interventions

In conclusion, the market for transjugular intrahepatic portosystemic shunt procedures is marked by dynamic changes that are rapidly redefining clinical practices and market structures. This comprehensive analysis has highlighted the significance of robust segmentation strategies, regional market trends, and competitive insights that together provide a holistic view of the industry landscape.

Innovation remains the cornerstone of progress in the TIPS market, with technological breakthroughs in accessory devices, stent designs, and procedural protocols playing a pivotal role in enhancing patient care. The evolution of both elective and emergency shunt procedures underscores a shift as stakeholders are increasingly focusing on precision, safety, and adaptability.

Strategic collaborations among industry leaders and continuous investments in R&D signal a future where high-performance devices become the norm. The dynamic interplay of market segmentation factors-from product types and material compositions to procedural approaches and end-user engagements-offers a detailed map for navigating the challenges and opportunities in this evolving space.

The insights presented herein empower decision-makers with the necessary tools to forge ahead in a competitive environment. By embracing innovation, improving operational efficiencies, and aligning with regional and global market trends, industry players can confidently steer the future of TIPS interventions toward enhanced clinical outcomes and sustained market growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of liver diseases such as cirrhosis and portal hypertension
      • 5.1.1.2. Increasing adoption of minimally invasive surgical procedures due to faster recovery times
    • 5.1.2. Restraints
      • 5.1.2.1. Safety concerns and potential complications associated with intrahepatic portosystemic shunt procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing personalized TIPS treatment plans leveraging artificial intelligence for better patient outcomes
      • 5.1.3.2. Capitalizing on technological advancements in materials to enhance TIPS device efficacy and safety
    • 5.1.4. Challenges
      • 5.1.4.1. Insufficient insurance coverage and reimbursement issues related to TIPS procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising need for accessory devices for minimally invasive surgical procedures
    • 5.2.2. Application: Increasing necessity for TIPS procedure for curing portal hypertension
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transjugular Intrahepatic Portosystemic Shunt Market, by Product Type

  • 6.1. Introduction
  • 6.2. Accessory Devices
    • 6.2.1. Balloon Expanders
    • 6.2.2. Catheters
    • 6.2.3. Guiding Wires
  • 6.3. Stents
    • 6.3.1. Bare Metal Stents
    • 6.3.2. Drug-Eluting Stents
    • 6.3.3. Sectional Stents

7. Transjugular Intrahepatic Portosystemic Shunt Market, by Procedure Type

  • 7.1. Introduction
  • 7.2. Elective Shunts
  • 7.3. Emergency Shunts

8. Transjugular Intrahepatic Portosystemic Shunt Market, by Material Type

  • 8.1. Introduction
  • 8.2. Metallic Stents
  • 8.3. Polymers

9. Transjugular Intrahepatic Portosystemic Shunt Market, by Application

  • 9.1. Introduction
  • 9.2. Budd-Chiari Syndrome
  • 9.3. Hepatitis C
  • 9.4. Liver Cirrhosis
  • 9.5. Portal Hypertension

10. Transjugular Intrahepatic Portosystemic Shunt Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Hospitals
  • 10.4. Research Institutes
  • 10.5. Specialty Clinics

11. Americas Transjugular Intrahepatic Portosystemic Shunt Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Transjugular Intrahepatic Portosystemic Shunt Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Transjugular Intrahepatic Portosystemic Shunt Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Argon Medical enhances TIPS procedure with innovative liver management devices
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AngioDynamics Inc.
  • 2. Argon Medical Devices, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Boston Scientific Corporation
  • 5. Cook Group Incorporated
  • 6. Medtronic
  • 7. Merit Medical Systems, Inc.
  • 8. Siemens Healthcare Limited
  • 9. Sirtex Medical Inc.
  • 10. Terumo Medical Corporation
  • 11. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET MULTI-CURRENCY
  • FIGURE 2. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET MULTI-LANGUAGE
  • FIGURE 3. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET RESEARCH PROCESS
  • FIGURE 4. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BALLOON EXPANDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY GUIDING WIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY SECTIONAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ELECTIVE SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY EMERGENCY SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BUDD-CHIARI SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PORTAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)

T